2024-03-29T00:49:34Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_05A38F987653
2024-03-23T01:48:17Z
serval:BIB_05A38F987653
Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.
10.1007/s00384-010-0939-0
20397022
000278290600001
Voutsadakis
I.A.
author
Patrikidou
A.
author
Tsapakidis
K.
author
Karagiannaki
A.
author
Hatzidaki
E.
author
Stathakis
N.E.
author
Papandreou
C.N.
author
article
2010
International Journal of Colorectal Disease
1432-1262[electronic], 0179-1958[linking]
journal
25
7
795-804
Apoptosis/drug effects
Aspirin/pharmacology
Blotting, Western
Boronic Acids/pharmacology
Cell Line, Tumor
Cell Proliferation/drug effects
Cell Survival/drug effects
Colorectal Neoplasms/enzymology
Colorectal Neoplasms/pathology
Cyclin-Dependent Kinase Inhibitor p21/metabolism
Cyclin-Dependent Kinase Inhibitor p27/metabolism
Cyclooxygenase 2/metabolism
Down-Regulation/drug effects
Drug Synergism
Humans
NF-kappa B/metabolism
Proto-Oncogene Proteins c-akt/metabolism
Pyrazines/pharmacology
bcl-Associated Death Protein/metabolism
eng
60_published
Publication types: Journal Article
Publication Status: ppublish